Given the rise of apoptosis-resistant tumors, exists a growing interest in developing new drugs capable of inducing different types of cell death to reduce colorectal cancer-related death rates. As apoptosis and necroptosis do not share cellular machinery, necroptosis induction may have a great therapeutic potential on those apoptosis-resistant cancers, despite the inflammatory effects associated with it.
INTRODUCTION
The use of metals with therapeutic purposes dates back to ancient times. Nevertheless one of the biggest successes for inorganic chemistry in medicine was the accidental discovery of antitumor properties of cisplatin in the 60s. cis-[PtCl 2 (NH 3 ) 2 ], commonly called cisplatin has been used worldwide in chemotherapy against various cancers including testicular, ovarian and solid tumors of head and neck [1, 2] . However, the use of platinum derivatives results in serious side effects related to their nonspecific mechanism of action [3] . Thus, in the last decades researchers have focused on finding new metal derivatives with anticancer properties that lack the shortcomings of cisplatin and its analogues.
In this context, gold complexes are an interesting alternative to platinum-containing drugs [1, 2] . Many gold(I) complexes have been tested against various tumor cell lines, [4] [5] [6] and some of these promising in vitro results have also been confirmed in vivo using animal models [4, 7, 8] . The main advantage of these compounds against platinum complexes is that they differ in their mechanism of action. Whereas platinum compounds interact with nucleic acids, gold-containing drugs display a higher variety of targets, including non-canonical DNA structures [9, 10] , zinc finger proteins [11] or the redox enzyme thioredoxin reductase (TrxR). Gold complexes are able to inhibit TrxR via interacting with the selenium atom [12] of the selenocysteine moiety. When TrxR is inhibited, the regular redox balance becomes disrupted and the abnormally increased levels of reactive oxygen species (ROS) trigger cell death [13] . Consequently, TrxR inhibition does not involve the side effects related to treatment with cisplatin and its analogues. In addition, there is not cross-resistance between them [14] . Therefore, goldcontaining drugs are able to induce cell death even in cisplatin-resistant cancer cells.
Colorectal cancer (CRC) is one of the most prevalent cancers in Western countries and one of the main causes of cancer-related death [15] . CRC is a kind of tumors which shows a good response to treatment with metallic compounds, since the combination of the cisplatin analogue oxaliplatin (cis-[oxalate(trans-l-1,2diaminocyclohexane)platinum(II)]) and traditional chemotherapy improves patient response versus traditional chemotherapy alone [16, 17] . Consequently, it is necessary to
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3 find new therapeutic options with fewer side effects than current treatments but maintaining their anticancer potential.
Treatment with metallic compounds usually induces apoptosis, one of the best characterized kinds of cell death [18, 19] . As an example, we have recently described in detail the apoptotic insights of an alkynyl gold(I) complex [20] . But, given the rise of apoptosis-resistant tumors exist a growing interest in developing new drugs capable of inducing different types of cell death [21] .
Necroptosis is a regulated form of necrosis mainly governed by Receptor-Interacting Protein 1 (RIP1), RIP3 and Mixed Lineage Kinase Domain-Like (MLKL) protein. A wide range of stimuli can start this process, although the best studied pathway is triggered by Tumor Necrosis Factor (TNF). TNF-triggered necroptosis requires the formation of "necrosome", a protein complex in which RIP1 and RIP3 are involved and responsible for MLKL phosphorylation. The necrosome migrates to plasma membrane and induces its rupture, [22, 23] so it is the ultimate responsible for necroptotic morphological features, i.e. cellular swelling and loss of intracellular content. Therefore, as apoptosis and necroptosis do not share the same molecular pathways, necroptosisinducing drugs may induce cell death on apoptosis-resistant tumors.
2D cell culture provides only a slanted vision of how cells behave inside human body;
therefore, results in 2D cannot always be translated into in vivo settings. To obtain more accurate information about cell response to that observed in vivo, 3D cell cultures have proved an useful alternative [24] . 3D cell models provide a more relevant microenvironment where cell-cell and cell-matrix interactions are promoted.
Particularly, cells acquire relevant features observed in tumors in vivo, such as distinctive morphological and cellular characteristics, as well as distinctive gene expression signature, which could account for the different drug response to that observed in 2D [25, 26] . Among the 3D cell culture methods, spheroids are one of the best characterized models so far. They closely recapitulate the tumor microenvironment, including hypoxia and metabolic gradients. Furthermore, previous studies in spheroids have provided insight on drug distribution and penetration. [27, 28] . All in all, cell spheroids are a 3D cell culture method usually used in drug-response studies [29, 30] .
Specifically, Caco-2 spheroids have been previously used in permeability assays as the obtained values were quite similar to those found in vivo [31] .
Here we describe the preparation and evaluation of the anticancer activity of the 
MATERIALS AND METHODS

Preparation of [Au(C≡C-2-NC 5 H 4 )(PTA)].
The alkynyl gold complex was prepared as described previously by some of us [33] . Pale yellow solid was isolated in 78% yield. 1 Barcelona, Spain). MCF-7 cells were maintained in the same conditions as described for Caco-2 cell line.
Cell proliferation assay and IC 50 value determination. Cell proliferation inhibition
was measured using the MTT assay [34] . Caco-2/TC7 cells were plated in 96-well plates at a density of 4000 cells/well and incubated for 24 h under standard cell culture conditions. For IC 50 values determination, a stock solution of the gold complex in dimethyl sulfoxide (DMSO) was added to cells in a concentration range of 0-20 μM (10 replicates, 100 µL per well); cells treated with the same amount DMSO were used as negative control. Cells were exposed to the gold complex for 24 h and then 10 µL of MTT (5 mg/ml) was added. Incubation was continued at 37ºC for 3 h. Medium was then removed by inversion and 100 µL of DMSO/well were added. Absorbance at 560 nmproportional to number of live cells-was measured by spectrophotometry (DTX 800, Beckman Coulter) and converted into percentage of growth inhibition.
Thioredoxin reductase activity assay in cells. Caco-2/TC7 were grown in 96-well plate at a density of 4.000 cells/well during 24h, and then treated with [Au(C≡C-2- Glutathione reductase activity of the cell lysate was measured as a loss in absorbance at 340 nm.
Measurements of apoptosis.
Caco-2/TC7 cells were exposed to IC 50 of [Au(C≡C-2-NC 5 H 4 )(PTA)] for 24 h, then collected and stained with Annexin V-FITC as described by Sánchez-de-Diego et al [20] . Untreated cells were used as negative control, in order to define basal levels of apoptosis, necrosis and cell death.
Propidium iodide staining of DNA content and cell cycle analysis. Caco-2/TC7 cells were exposed to IC 50 of [Au(C≡C-2-NC 5 H 4 )(PTA)] for 24 h and then DNA content was analyzed as described by Sánchez-de-Diego et al [20] .
Caspase activity studies. Caspase activation was studied using CellEvent TM Caspase- Figure S3 ). With these results, this complex can be considered sufficiently stable in the solution to be tested on cells.
The lipophilicity of a compound is associated to its diffusion and penetration into the cell membrane. Consequently, drug lipophilicity affects its activity, toxicity to healthy tissues and is directly related to plasma protein binding and metabolism of the drug [37] . Changes in drug lipophilicity by incorporating the suitable functional groups in the molecule have shown great impact in anticancer activity and host toxicity [38, 39] .
However, phosphane gold(I) derivatives with high lipophilicity [39] tend to accumulate into mitochondria with the consequent serious effects [40] . Subsequently, a balanced relationship between lipophilicity and hydrophilicity would be highly desirable.
Lipophilicity can be measured by the partition coefficient water/octanol, logD 7.4 , which finally shows the corresponding balance between lipophilicity and hydrophilicity. The measurement of logD 7.4 of our alkynyl derivative (see experimental for details) gave a negative value next to 0 (-0.10). This is in accordance with slight hydrophilic character of the complex, albeit with a balanced relationship between both characters.
Binding to BSA. The distribution, free concentration and metabolism of a drug are affected by drug-protein interactions in the bloodstream [41, 42] . Such interaction can influence drug stability and toxicity during chemotherapeutic treatment, thereafter limiting drug efficacy. Consequently, it is important to understand the potential presence and nature of these interactions. One of the blood plasma proteins involved in drug transport is serum albumin. Bovine serum albumin (BSA) is frequently used in biochemical analysis due to its higher stability and accessibility. BSA contains two tryptophan residues (Trp-134 and Trp-212) in the former while HAS (human serum albumin) has a unique tryptophan. Hence, we have studied the interaction of [Au(C≡C-2-NC 5 H 4 )(PTA)] with BSA by means of the measurement of the quenching of the intrinsic fluorescence of the amino acid tryptophan, which is sensitive to its local environment. Accordingly, any changes in the fluorescence emission spectra can be attributable to changes in the conformation, due to the presence of the quencher [43] .
The fluorescence spectra of BSA were recorded in the presence of increasing amounts of the gold complex in the range of 310-450nm upon excitation at 295 nm. Quenching of the fluorescence is observed in a concentration dependent manner, without changes in the emission maximum and shape of the peaks ( Figure 1A ). This fact points to an interaction of the gold complex with the protein without alteration of the vicinity of the tryptophan residues.
The quenching process can be due to the presence of collisions between a fluorophore with the quenching agent ˗dynamic quenching˗ or the formation of a non-fluorescent complex with the quenching agent, i.e. static quenching. Fluorescence data were analyzed by the Stern-Volmer equation: F 0 /F = 1+ K sv [1] , where F 0 and F are the steady sate fluorescence intensities of BSA before and after the addition of the gold complex.
While a linear Stern-Volmer plot (F 0 /F vs.
[quencher]) is indicative of the occurrence of a single quenching mechanism, the plot F 0 /F vs with a positive deviation ( Figure 1B) suggests the presence of a combination or static and dynamic quenching. Moreover, the upward curvature in the plot indicates that both tryptophan residues in the BSA molecule are exposed to the gold complex [44] .
The modified Stern-Volmer equation: provides the corresponding binding constant K b , by using the plot of log(F 0 -F)/F vs log[1], ( Figure   1C ). The binding constant was found to be 2.3·10 8 M -1 , which indicates a high affinity of our complex to the protein, and inversely decreases with the temperature. This high value points to a strong interaction between BSA and the gold complex. Figure S8) ).
The interaction forces of biomolecules and drugs involve hydrophobic forces, electrostatic interactions, van der Waals interactions or hydrogen bonds [45] . The negative value calculated for Gº is indicative of a spontaneous process and the negative values for both enthalpy and entropy of the interaction are consistent with the presence of van der Waals interaction and hydrogen bonds [45] .
In addition, we have measured the UV-visible absorption spectra of the BSA in presence and in absence of the gold complex (figure S13). The absorption spectrum of C protein is only influences by complexation with quencher in ground state (static process). In our case a hyperchromism is observed after addition of the complex, which is in accordance with alteration in the microenvironment around the aromatic acid residues, whereas the presence of hypochromism is associated to an induced perturbation of -helix of the protein with the quencher [46] . Table T1 ).
Then we investigated two common apoptotic features: cell cycle arrest [48] (Figure 3 (Figure 3.2) , showing a clear swelling that is not a typical apoptotic feature [18, 19] . The absence of apoptotic biomarkers in addition to the statements of Pietkiewicz et al [49] ˗it is impossible to distinguish between late apoptotic and necroptotic cells by using the classical double staining annexin V-PI˗ were evidences of a different type of cell death induction than apoptosis. Thus, we investigated necroptosis induction. [Au(C≡C-2-NC 5 H 4 )(PTA)] does not bind DNA. We evaluated the possible interaction of this alkynyl derivative with DNA by monitoring its influence on pIRES2-EGFP (5308 pb) plasmid DNA by agarose gel electrophoresis in comparison to cisplatin. Figure S10 displays that mobility of the plasmid is not affected after incubation with increasing amounts of our gold derivative, unlike the variation observed with the reference drug. This lack of DNA interaction is shared with auranofin and other gold(I) derivatives [20, 50] . derivative is very soluble in water, shows the formation of gel structure in water solution, giving rise to long fibers, thanks to π-π interactions between the pyridyl units.
The occurrence of similar π-π interactions in our complex between the PTA molecule and the pyridyl unit is less probable, since any trace data could be retrieved from the corresponding 2D-NOESY spectrum, ( Figure S9) . Viability studies revealed that our gold compound induced cell death in a tumor-like environment (Figure 8 ), which suggests that its anticancer properties may remain unchanged into a living organism. It is remarkable that, although in 3D model the decrease in viability observed was lower than the found in 2D for the same gold complex concentrations, cell properties differ greatly between each experiment as has been widely discussed previously. Consequently, these results support our initial hypothesis that this gold(I) complex has a considerable antitumor potential and it is not ruled out its chemotherapeutic use in the future. 
